. . . . . . . . . "nly a few medications are available for the treatment of alcohol use disorders (AUDs). Areas covered: This paper discusses approved AUD medications, including the opioid antagonists naltrexone and nalmefene (the latter is licensed for reduction of alcohol consumption only), the putative glutamate receptor antagonist acamprosate and the aldehyde dehydrogenase inhibitor disulfiram. It also covers off-label medications of interest, including topiramate, gabapentin, ondansetron, varenicline, baclofen, sodium oxybate and antidepressants." . . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "jeLBHsuUvsMdpK+yTeiGKnslFJ62Ok6aU3Avzs5TWiBSIJBTfQU3i36iUTypz+QhygVSY8gbi8jrFxhutgZ+1KE37rxxXx90C3Ki9covQ+CsI37DVncFf6YcjmWD52sYMSXjA8PLS50qYyoXVoYSwLoh09vMVyaywf+xa6pYF2g=" . . "2021-08-25T19:58:40.391+02:00"^^ . . . . . . .